PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers uncover key therapeutic target involved in diabetic atherosclerosis

2024-02-29
(Press-News.org) Diabetes accelerates the development of atherosclerosis, increasing the incidence of cardiovascular events. In atherosclerosis, immune cells called macrophages release molecules such as chemokines and cytokines, causing inflammation and leading to arterial plaque formation. However, significant gaps persist in understanding the exact molecular mechanisms controlling this increased inflammatory response in individuals with diabetes. In a new, preclinical study, researchers from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, identified a long non-coding RNA (lncRNA) sequence that could help them unravel the complex processes underlying diabetic atherosclerosis, potentially paving the way for future therapeutic interventions in humans.

Through genetic analysis of a mouse model of diabetic atherosclerosis, the research team identified a specific sequence of long-noncoding RNA, they named MERRICAL, which is involved in recruiting macrophages to the arterial wall. As atherosclerosis progressed in these mice, the researchers found a notable increase in the expression of MERRICAL at arterial lesions—areas where atherosclerosis plaque built up and damaged the arteries. Furthermore, when the research team therapeutically delivered inhibitors to reduce MERRICAL expression levels, they observed an impressive reduction in macrophage recruitment and in atherosclerosis and aortic lesion formation (74 percent in the aortic sinus and 86 percent in the descending aorta).

“Our work provides new insights for targets that underlie the impaired responses in the vessel walls in diabetes and identifies a key therapeutic target for reversing the accelerated atherosclerosis in diabetes,” said Mark W. Feinberg, MD, a cardiologist and Associate Professor of Medicine of the Brigham’s Heart and Vascular Center and Harvard Medical School, Boston.

in Cell Reports.

END


ELSE PRESS RELEASES FROM THIS DATE:

Scripps Research scientists reveal how first cells could have formed on Earth

Scripps Research scientists reveal how first cells could have formed on Earth
2024-02-29
LA JOLLA, CA—Roughly 4 billion years ago, Earth was developing conditions suitable for life. Origin-of-life scientists often wonder if the type of chemistry found on the early Earth was similar to what life requires today. They know that spherical collections of fats, called protocells, were the precursor to cells during this emergence of life. But how did simple protocells first arise and diversify to eventually lead to life on Earth? Now, Scripps Research scientists have discovered one plausible pathway for how protocells may have first formed and chemically ...

EcoFABs could lead to better bioenergy crops

EcoFABs could lead to better bioenergy crops
2024-02-29
– By Will Ferguson A greater understanding of how plants and microbes work together to store vast amounts of atmospheric carbon in the soil will help in the design of better bioenergy crops for the fight against climate change.  Deciphering the mechanics of this mutually beneficial relationship is challenging, however, as conditions in nature are extremely difficult for scientists to replicate in the laboratory. To address this challenge, researchers at Lawrence Berkeley National Laboratory (Berkeley Lab) created fabricated ecosystems or EcoFABs.  In a new paper in Science Advances, they ...

Digital Science announces Catalyst Grant winners, supporting AI-based innovations to benefit research

Digital Science announces Catalyst Grant winners, supporting AI-based innovations to benefit research
2024-02-29
Digital Science has awarded two new Catalyst Grants of £25,000 each to innovative AI-based technology ideas aimed at advancing global research. The winners will use the funding to develop their ideas, which include using AI to alleviate the burden on researchers of applying for research funding, and to predict research impact. The winning applications from Digital Science’s 2023 Catalyst Grant round announced today are: Atom – Tomer du Sautoy (co-founder and CEO) and Hamilton Evans (co-founder and ...

Targeting seed microbes to improve seed resilience

Targeting seed microbes to improve seed resilience
2024-02-29
Fonio (Digitaria exilis), a type of millet, is the oldest indigenous crop in West Africa and one of the fastest maturing cereals. Despite its low yield, the combination of quick maturation and drought tolerance and its ability to thrive in poor soils make it a useful model for understanding how cereals can adapt to future climate change conditions. Nutritionally, fonio is comparable to other millets, says KAUST researcher Naheed Tabassum, but yields are much lower than the major cereal crops rice, maize and wheat. Tabassum believes fonio could complement staple crops amid climate change and desertification ...

Astronomers discover heavy elements after bright gamma-ray burst from neutron star merger

Astronomers discover heavy elements after bright gamma-ray burst from neutron star merger
2024-02-29
An international team of astronomers — including Clemson University astrophysicist Dieter Hartmann — obtained observational evidence for the creation of rare heavy elements in the aftermath of a cataclysmic explosion triggered by the merger of two neutron stars. The massive explosion unleashed a gamma-ray burst, GRB230307A, the second brightest in 50 years of observations and about 1,000 times brighter than a typical gamma-ray burst. GRB230307A was first detected by NASA’s Fermi Gamma-Ray Space Telescope on March 7, 2023. Using multiple space- and ground-based ...

USTC reveals molecular mechanism of transmembrane bilirubin transport by human ABCC2 transporter

USTC reveals molecular mechanism of transmembrane bilirubin transport by human ABCC2 transporter
2024-02-29
The metabolic process of bilirubin has been a focus in medical research since the abnormal accumulation of bilirubin has been found to be associated with a variety of diseases. Bilirubin is a substance produced by the breakdown of aging or damaged red blood cells, and its effective removal is essential for human health.  A research team led by Prof. CHEN Yuxing and Prof. ZHOU Congzhao from the University of Science and Technology of China (USTC) of the Chinese Academy of Sciences has revealed the three-dimensional structure and working mechanism of the human bilirubin transporter ABCC2. The study was published ...

USTC realizes durable CO2 conversion in proton-exchange membrane system

USTC realizes durable CO2 conversion in proton-exchange membrane system
2024-02-29
The metabolic process of bilirubin has been a focus in medical research since the abnormal accumulation of bilirubin has been found to be associated with a variety of diseases. Bilirubin is a substance produced by the breakdown of aging or damaged red blood cells, and its effective removal is essential for human health.  A research team led by Prof. CHEN Yuxing and Prof. ZHOU Congzhao from the University of Science and Technology of China (USTC) of the Chinese Academy of Sciences has revealed ...

A new plant’s name that tells a story

A new plant’s name that tells a story
2024-02-29
A new species and genus of fairy lantern, tiny glass-like white plants that feed on fungi, has been discovered in Japan. In the country renowned for its extensive flora research, the discovery of a new plant genus is extremely rare and has not occurred in almost 100 years. Fairy lanterns, or Thismiaceae as they are known to botany, are very unusual plants found mainly in tropical but also in subtropical and temperate regions. First of all, they are not green and do not engage in photosynthesis, but rather feed on fungal mycelia in the ground. As a consequence, they are often hidden under fallen leaves and only for a brief period produce above-ground flowers that look like glasswork. The ...

Noteworthy studies to be presented at the 2024 Multidisciplinary Head & Neck Cancers Symposium

2024-02-29
PHOENIX, February 29, 2024 — Research on patient-centered treatment of head and neck cancers will be presented at the 2024 Multidisciplinary Head and Neck Cancers Symposium, which takes place in Phoenix and online today through March 2. Media registration is available via our press kit, and general registration is available via the meeting website. Seven high-impact studies recommended by symposium leadership for media are noted below. All abstracts are available online. Experts are available to provide outside commentary and perspective on research at the meeting; ...

Turbocharging CRISPR to understand how the immune system fights cancer

2024-02-29
Over the past two decades, the immune system has attracted increasing attention for its role in fighting cancer. As researchers have learned more and more about the cancer-immune system interplay, several antitumor immunotherapies have become FDA-approved and are now regularly used to treat multiple cancer types. Yet despite these advances, much remains unknown about how the immune system fights cancer — and about immunity in general, said Martin LaFleur, a postdoctoral fellow in the laboratory of Arlene ...

LAST 30 PRESS RELEASES:

Preschool education: A key to supporting allophone children

CNIC scientists discover a key mechanism in fat cells that protects the body against energetic excess

Chemical replacement of TNT explosive more harmful to plants, study shows

Scientists reveal possible role of iron sulfides in creating life in terrestrial hot springs

Hormone therapy affects the metabolic health of transgender individuals

Survey of 12 European countries reveals the best and worst for smoke-free homes

First new treatment for asthma attacks in 50 years

Certain HRT tablets linked to increased heart disease and blood clot risk

Talking therapy and rehabilitation probably improve long covid symptoms, but effects modest

Ban medical research with links to the fossil fuel industry, say experts

Different menopausal hormone treatments pose different risks

Novel CAR T cell therapy obe-cel demonstrates high response rates in adult patients with advanced B-cell ALL

Clinical trial at Emory University reveals twice-yearly injection to be 96% effective in HIV prevention

Discovering the traits of extinct birds

Are health care disparities tied to worse outcomes for kids with MS?

For those with CTE, family history of mental illness tied to aggression in middle age

The sound of traffic increases stress and anxiety

Global food yields have grown steadily during last six decades

Children who grow up with pets or on farms may develop allergies at lower rates because their gut microbiome develops with more anaerobic commensals, per fecal analysis in small cohort study

North American Early Paleoindians almost 13,000 years ago used the bones of canids, felids, and hares to create needles in modern-day Wyoming, potentially to make the tailored fur garments which enabl

Higher levels of democracy and lower levels of corruption are associated with more doctors, independent of healthcare spending, per cross-sectional study of 134 countries

In major materials breakthrough, UVA team solves a nearly 200-year-old challenge in polymers

Wyoming research shows early North Americans made needles from fur-bearers

Preclinical tests show mRNA-based treatments effective for blinding condition

Velcro DNA helps build nanorobotic Meccano

Oceans emit sulfur and cool the climate more than previously thought

Nanorobot hand made of DNA grabs viruses for diagnostics and blocks cell entry

Rare, mysterious brain malformations in children linked to protein misfolding, study finds

Newly designed nanomaterial shows promise as antimicrobial agent

Scientists glue two proteins together, driving cancer cells to self-destruct

[Press-News.org] Researchers uncover key therapeutic target involved in diabetic atherosclerosis